Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

A new drug is transforming the lives of children born with a severe form of epilepsy, say doctors and families. Dravet syndrome can cause dozens of dangerous seizures a day and affects about one in ...

Xenon Pharmaceuticals (XENE) stock soared 40% after Phase 3 trial data for azetukalner exceeded expectations in focal onset seizures. FDA filing set for Q3 2026.

Marijuana extract shown to cut life-threatening seizures in half for children with severe epilepsy. A landmark clinical trial has revealed that a drug derived from medical marijuana can significantly ...

An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by ...

Praxis Precision Medicines has received Breakthrough Therapy Designation (BTD) from the FDA for relutrigine, a sodium channel modulator intended for pediatric treatment of SCN2A and SCN8A ...

Praxis Precision Medicines said federal regulators have granted their breakthrough therapy designation, or BTD, to its seizure treatment, relutrigine. The clinical-stage biopharmaceutical company said ...

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London in partnership with the Mayo Clinic and UNEEG medical, has found that an electronic device ...

The last time I spoke about Bright Minds Biosciences (DRUG) it was with respect to an article entitled "Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101".

Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure freedom New X-TOLE OLE data analysis supports the ability ...

Consistent sleep, structured routines, and supportive workplaces play a vital role in reducing seizure frequency and improving quality of life for people living with epilepsy.